News
a global pharmaceutical company focusing on scientific and technological innovation, announced on March 25 that it has entered into an exclusive license agreement with United States-based Merck, ...
Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.
Hosted on MSN15d
The Truth Big Pharma Won’t Want You to KnowHere's the Average Social Security Benefit at Ages 62, 67, and 70 We may not be alone in the universe: Astronomers find possible alien life on planet Hollywood’s new A-list are rejecting ...
NEW DELHI, Apr 7: Sun Pharmaceutical Industries on Monday said it has introduced a medication for the treatment of Erosive Esophagitis of all grades. The Mumbai-based drug major, in a statement, said ...
Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite India's strong presence in the US generics market, potential tariffs may ...
Still, drugmakers aren’t in the clear. Trump singled them out in his remarks Wednesday, saying: “The pharmaceutical companies are going to come roaring back… because if they don’t ...
Hosted on MSN19d
Did pharma sector dodge Trump’s tariffs? The EU's not so sureBelgium, home to US Pfizer’s major European production facilities, exported over $73 billion in pharmaceuticals in the first 10 months of 2024, with 25% going to the US. PM meets Bangladesh's ...
SAN FRANCISCO, April 1, 2025 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. (Yingli Pharma), a clinical stage biotechnology company developing oral small molecule drugs for cancer, metabolic ...
M.D., Merck’s head of general medicine, global clinical development, said in an interview with Fierce Pharma. “There has not been a PH study that used an endpoint based on death ...
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...
In this special edition of Market Master, Madhu Kela, Founder of MK Ventures, discusses India's CDMO potential with industry leaders Satyanarayana Chava, Founder and CEO of Laurus Labs, and Neeraj ...
President Donald Trump announced upcoming tariffs on the pharmaceutical industry, without elaborating on specifics. He also mentioned being open to negotiating deals with other countries after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results